RecruitingPhase 2NCT04049331
Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone
Studying Rare male infertility due to testicular endocrine disorder
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Seattle Institute for Biomedical and Clinical Research
- Principal Investigator
- Jose M Garcia, MD, PhDVA Puget Sound Health Care System
- Intervention
- Testosterone Undecanoate 750 MG/3 ML Intramuscular Solution [AVEED](drug)
- Enrollment
- 240 enrolled
- Eligibility
- 18-54 years · MALE
- Timeline
- 2021 – 2027
Study locations (2)
- Brigham and Women's Hospital, Boston, Massachusetts, United States
- Veterans Affairs Puget Sound Health Care System, Seattle, Washington, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04049331 on ClinicalTrials.gov